745 results on '"Herrmann, Howard C"'
Search Results
2. Neutrophil‐to‐Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and Registries
3. Patient-Prosthesis Mismatch After Surgical Aortic Valve Replacement: Analysis of the PARTNER Trials
4. Incidence, Implications, and Treatment of Patients With Severe Aortic Stenosis and Small Aortic Annulus
5. Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction
6. 2023 ACC/AHA/SCAI advanced training statement on interventional cardiology (coronary, peripheral vascular, and structural heart interventions): A report of the ACC Competency Management Committee
7. First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System
8. Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry
9. Very early infective endocarditis after transcatheter aortic valve replacement
10. Cardiology Assessment of Patients Undergoing Evaluation for Orthotopic Liver Transplantation
11. Sex Differences in Infective Endocarditis After Transcatheter Aortic Valve Replacement
12. Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review
13. Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps: JACC State-of-the-Art Review
14. SCAI Publications Committee Manual of Standard Operating Procedures: 2022 Update
15. Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation
16. Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement
17. Rationale and design of the SMall Annuli Randomized To Evolut or SAPIEN Trial (SMART Trial)
18. Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial
19. Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry
20. The Clinical Implications of Body Surface Area as a Poor Proxy for Cardiac Output
21. Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry
22. Impact of Echocardiographic Parameters on Recurrent Stroke in the Randomized REDUCE PFO Cryptogenic Stroke Trial
23. Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement
24. Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: Results From the Multicenter International BASILICA Registry
25. Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT Trial
26. Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk
27. ICE-guided percutaneous non-coronary interventional procedures
28. Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease
29. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement
30. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry
31. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
32. Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement
33. Self-Expanding Valve System for Treatment of Native Aortic Regurgitation by Transcatheter Aortic Valve Implantation (from the STS/ACC TVT Registry)
34. 3-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprostheses: The PARTNER 2 Registry
35. Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients
36. Prosthesis–Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry
37. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years
38. Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Arteries
39. Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials
40. Lack of Association Between Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement Outcomes in New York Hospitals
41. Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial
42. The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry
43. Impact of Resting Heart Rate at 30 Days Following Transcatheter or Surgical Aortic Valve Replacement and Cardiovascular Outcomes: Insights from The PARTNER 2 Trial
44. Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve
45. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial
46. Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The TOPAS-TAVI Registry
47. Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts
48. LB-9 | Self-Expanding Versus Balloon-Expandable Transcatheter Aortic Valve Replacement in Patients with Small Aortic Annuli: Additional Outcomes from the SMART Trial
49. OR4-1 | In-hospital Results with Intravascular Lithotripsy in the Real-World: Outcomes from the ACC NCDR® CathPCI Registry®
50. Patient and Staff Perceptions of Universal Severe Acute Respiratory Syndrome Coronavirus 2 Screening Prior to Cardiac Catheterization and Electrophysiology Laboratory Procedures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.